This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2007;67(17):2481-5; discussion 2491-3.

doi: 10.2165/00003495-200767170-00001.

Comment on "adjuvant therapy in pancreatic cancer: a critical appraisal"

Ross A Abrams¹

Affiliations

PMID: 18034585
DOI: 10.2165/00003495-200767170-00001

Review

Comment on "adjuvant therapy in pancreatic cancer: a critical appraisal"

Ross A Abrams. Drugs. 2007.

. 2007;67(17):2481-5; discussion 2491-3.

doi: 10.2165/00003495-200767170-00001.

Author

Ross A Abrams¹

Affiliation

¹ Department of Radiation Oncology, Rush University Medical Center, Chicago, Illinois 60612-3833, USA. Ross_A_Abrams@Rush.edu

PMID: 18034585
DOI: 10.2165/00003495-200767170-00001

No abstract available

PubMed Disclaimer

Comment on

Adjuvant therapy in pancreatic cancer: a critical appraisal.
Oettle H, Neuhaus P. Oettle H, et al. Drugs. 2007;67(16):2293-310. doi: 10.2165/00003495-200767160-00001. Drugs. 2007. PMID: 17983252 Review.

Similar articles

Comment on "adjuvant therapy in pancreatic cancer: a critical appraisal".
Ghaneh P, Tudur-Smith C, Neoptolemos JP. Ghaneh P, et al. Drugs. 2007;67(17):2487-90; discussion 2491-3. doi: 10.2165/00003495-200767170-00002. Drugs. 2007. PMID: 18034586 Review. No abstract available.
Role of adjuvant therapy in the management of pancreatic cancer.
Laheru D, Yeo CJ. Laheru D, et al. Adv Surg. 2005;39:223-44. doi: 10.1016/j.yasu.2005.05.003. Adv Surg. 2005. PMID: 16250554 Review. No abstract available.
Adjuvant and neoadjuvant approaches to treat surgically resectable pancreatic cancer.
Keedy VL, Berlin J. Keedy VL, et al. Curr Treat Options Oncol. 2006 Sep;7(5):381-8. doi: 10.1007/s11864-006-0006-9. Curr Treat Options Oncol. 2006. PMID: 16904055 Review.
Chemoradiotherapy for pancreatic cancer: current status and perspectives.
Oya N. Oya N. Int J Clin Oncol. 2004 Dec;9(6):451-7. doi: 10.1007/s10147-004-0449-6. Int J Clin Oncol. 2004. PMID: 15616875 Review.
Preoperative chemoradiation therapy for pancreatic cancer.
Evans DB, Pisters PW. Evans DB, et al. Surg Clin North Am. 2001 Jun;81(3):709-13. doi: 10.1016/s0039-6109(05)70156-0. Surg Clin North Am. 2001. PMID: 11459284

See all similar articles

Cited by

Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704--a phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas.
Abrams RA, Winter KA, Regine WF, Safran H, Hoffman JP, Lustig R, Konski AA, Benson AB, Macdonald JS, Rich TA, Willett CG. Abrams RA, et al. Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):809-16. doi: 10.1016/j.ijrobp.2010.11.039. Epub 2011 Feb 1. Int J Radiat Oncol Biol Phys. 2012. PMID: 21277694 Free PMC article. Clinical Trial.

References

1. Semin Radiat Oncol. 2005 Oct;15(4):235-44 - PubMed
1. Oncology. 2006;70(4):255-64 - PubMed
1. Arch Surg. 1985 Aug;120(8):899-903 - PubMed
1. Semin Oncol. 1994 Aug;21(4 Suppl 7):58-66 - PubMed
1. N Engl J Med. 1998 Jul 2;339(1):21-6 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Springer
Medical
- MedlinePlus Health Information